• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危和局部晚期前列腺癌的根治性前列腺切除术:梅奥诊所观点

Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective.

作者信息

Stewart Suzanne B, Boorjian Stephen A

机构信息

Department of Urology, Mayo Clinic, Roschester, MN.

Department of Urology, Mayo Clinic, Roschester, MN.

出版信息

Urol Oncol. 2015 May;33(5):235-44. doi: 10.1016/j.urolonc.2014.10.003. Epub 2014 Nov 4.

DOI:10.1016/j.urolonc.2014.10.003
PMID:25459359
Abstract

PURPOSE

Men diagnosed with high-risk prostate cancer represent the cohort of prostate cancer patients at greatest risk for subsequent disease-specific mortality. Unfortunately, however, the classification of high-risk tumors remains imprecise and heterogeneous. There has been a historical reluctance to offer such patients aggressive local treatment, and considerable debate exists regarding the optimal management in this setting.

METHODS

We present here our institutional experience, as well as data from several other centers, with radical prostatectomy for high-risk tumors.

RESULTS

We discuss that surgery affords accurate pathological staging, thereby improving the identification of patients for secondary therapies. Moreover, prostatectomy not only provides durable local disease control but in addition numerous contemporary surgical series in high-risk patients have shown radical prostatectomy to be associated with excellent long-term cancer-specific survival. Further, although studies comparing surgical and radiotherapy modalities in high-risk prostate patients have been wrought with methodological challenges, consistently these observational studies have found equivalent to improved oncologic outcomes when surgery is utilized as the primary treatment.

CONCLUSIONS

Herein, we review the advantages, long-term outcomes, and technique of surgery for high-risk prostate cancer.

摘要

目的

被诊断为高危前列腺癌的男性是前列腺癌患者中后续疾病特异性死亡风险最高的群体。然而,不幸的是,高危肿瘤的分类仍然不精确且存在异质性。历史上一直不愿意为这类患者提供积极的局部治疗,并且对于这种情况下的最佳管理存在相当大的争议。

方法

我们在此介绍我们机构的经验,以及其他几个中心关于高危肿瘤根治性前列腺切除术的数据。

结果

我们讨论了手术能提供准确的病理分期,从而改善对二次治疗患者的识别。此外,前列腺切除术不仅能提供持久的局部疾病控制,而且众多针对高危患者的当代手术系列研究表明,根治性前列腺切除术与优异的长期癌症特异性生存率相关。此外,尽管比较高危前列腺癌患者手术和放疗方式的研究面临诸多方法学挑战,但这些观察性研究一致发现,当手术作为主要治疗方法时,肿瘤学结局相当甚至更好。

结论

在此,我们回顾了高危前列腺癌手术的优势、长期结局和技术。

相似文献

1
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective.高危和局部晚期前列腺癌的根治性前列腺切除术:梅奥诊所观点
Urol Oncol. 2015 May;33(5):235-44. doi: 10.1016/j.urolonc.2014.10.003. Epub 2014 Nov 4.
2
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.根治性前列腺切除术治疗 cT3 前列腺癌 20 年生存。
BJU Int. 2012 Dec;110(11):1709-13. doi: 10.1111/j.1464-410X.2012.11372.x. Epub 2012 Aug 30.
3
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.自前列腺特异性抗原检测出现以来,针对临床晚期(cT3)前列腺癌的根治性前列腺切除术:15年的结果。
BJU Int. 2005 Apr;95(6):751-6. doi: 10.1111/j.1464-410X.2005.05394.x.
4
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.根治性前列腺切除术对癌症控制和功能结局的长期影响的批判性分析。
Eur Urol. 2012 Apr;61(4):664-75. doi: 10.1016/j.eururo.2011.11.053. Epub 2011 Dec 7.
5
Controversies in the management of localized prostate cancer: radical prostatectomy still the standard of care.局部前列腺癌治疗的争议:根治性前列腺切除术仍是标准治疗方法。
Crit Rev Oncol Hematol. 2012 Dec;84 Suppl 1:e24-9. doi: 10.1016/j.critrevonc.2010.09.004. Epub 2011 May 25.
6
High-risk localized prostate cancer: role of radical prostatectomy.高危局限性前列腺癌:根治性前列腺切除术的作用。
Curr Opin Urol. 2010 May;20(3):204-10. doi: 10.1097/MOU.0b013e3283384101.
7
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
8
Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancer.65 岁及以上低危前列腺癌患者行根治性前列腺切除术的疗效。
J Urol. 2012 May;187(5):1620-5. doi: 10.1016/j.juro.2011.12.072. Epub 2012 Mar 14.
9
[The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].[采用根治性前列腺切除术或放射疗法治疗局部晚期(T3期)前列腺癌。综述]
Tijdschr Gerontol Geriatr. 1998 Apr;29(2):74-9.
10
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

引用本文的文献

1
XGBoost model for predicting erectile dysfunction risk after radical prostatectomy: development and validation using machine learning.用于预测前列腺癌根治术后勃起功能障碍风险的XGBoost模型:基于机器学习的开发与验证
Discov Oncol. 2025 May 19;16(1):810. doi: 10.1007/s12672-025-02685-y.
2
A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer.高危前列腺癌当前治疗模式综述
Cancers (Basel). 2021 Aug 24;13(17):4257. doi: 10.3390/cancers13174257.
3
Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer.
保留 Retzius 间隙的机器人辅助腹腔镜根治性前列腺切除术:在侵袭性和局部进展性前列腺癌中的功能和早期肿瘤学结果。
BMC Urol. 2019 Nov 12;19(1):113. doi: 10.1186/s12894-019-0550-9.
4
Radical prostatectomy for high-risk prostate cancer | Opinion: YES.高危前列腺癌的根治性前列腺切除术 | 观点:支持
Int Braz J Urol. 2019 May-Jun;45(3):424-427. doi: 10.1590/S1677-5538.IBJU.2019.03.02.
5
The long-term outcomes of radical prostatectomy for very high-risk prostate cancer pT3b-T4 N0-1 on definitive histopathology.根治性前列腺切除术治疗经最终组织病理学确诊的极高风险前列腺癌(pT3b-T4 N0-1)的长期结局
Cent European J Urol. 2017;70(1):13-19. doi: 10.5173/ceju.2017.897. Epub 2017 Jan 3.
6
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?对高危与极高危前列腺癌进行分类:这与适形放疗和雄激素剥夺治疗的结果相关吗?
Radiat Oncol. 2017 Jan 6;12(1):5. doi: 10.1186/s13014-016-0743-2.
7
Cytoreductive surgery for men with metastatic prostate cancer.转移性前列腺癌患者的细胞减灭性手术。
Prostate Int. 2016 Sep;4(3):103-6. doi: 10.1016/j.prnil.2015.11.003. Epub 2015 Dec 12.
8
[Multimodal therapy of locally advanced prostate cancer].[局部晚期前列腺癌的多模态治疗]
Urologe A. 2016 Mar;55(3):333-44. doi: 10.1007/s00120-016-0046-0.
9
[Localized intermediate- to high-risk prostate cancer].[局限性中高危前列腺癌]
Urologe A. 2016 Mar;55(3):318-25. doi: 10.1007/s00120-016-0039-z.
10
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?前列腺切除术后图像引导调强放疗的原理与发展:当前的护理标准?
Cancer Manag Res. 2015 Nov 11;7:331-44. doi: 10.2147/CMAR.S51955. eCollection 2015.